Abstract
In this paper, a hybrid heuristic rule-based and deterministic optimization-driven process decision framework is presented for the analysis and optimization of process flowsheets for end-to-end optimal (E2E0) pharmaceutical manufacturing. The framework accommodates various operating modes, such as batch, semi-batch and continuous, for the different unit operations that implement each manufacturing step. To address the challenges associated with solving process synthesis problems using a simulation-optimization approach, heuristic-based process synthesis rules are employed to facilitate the reduction of the superstructure into smaller sub-structures that can be more readily optimized. The practical application of the framework is demonstrated through a case study involving the end-to-end continuous manufacturing of an anti-cancer drug, lomustine. Alternative flowsheet structures are evaluated in terms of the sustainability metric, E-factor while ensuring compliance with the required production targets and critical product quality attributes.